CASI
CASI Pharmaceuticals Inc
NASDAQ: CASI · HEALTHCARE · BIOTECHNOLOGY
$0.21
+0.00% today
Updated 2026-04-29
Market cap
$3.21M
P/E ratio
—
P/S ratio
0.12x
EPS (TTM)
$-3.02
Dividend yield
—
52W range
$0 – $3
Volume
1.0M
CASI Pharmaceuticals Inc (CASI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-184.00%
Operating margin
-333.10%
ROE
-1,095.00%
ROA
-61.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2005 | $5.92M | $-16.31M | 100.00% | 292.79% | -275.65% |
| 2006 | $6.89M | $-49.89M | 100.00% | 749.20% | -723.62% |
| 2007 | $7.40M | $-22.41M | 100.00% | 320.87% | -303.03% |
| 2008 | $7.48M | $-23.86M | 100.00% | 299.00% | -319.13% |
| 2009 | $5.28M | $-8.22M | 100.00% | 127.21% | -155.49% |
| 2010 | $3.69M | $-8.10M | 100.00% | -122.78% | -219.35% |
| 2011 | $1.94M | $-4.56M | 100.00% | -235.36% | -234.87% |
| 2012 | $669310.00 | $-14.55M | 100.00% | 672.93% | -2,173.17% |
| 2013 | $0.00 | $-5.74M | — | — | — |
| 2014 | $23727.00 | $-26.20M | 68.53% | 110,370.00% | -110,432.45% |
| 2015 | $47712.00 | $-7.21M | 86.85% | 14,990.78% | -15,104.01% |
| 2016 | $0.00 | $-9.45M | — | — | — |
| 2017 | $0.00 | $-10.77M | — | — | — |
| 2018 | $0.00 | $-27.47M | — | — | — |
| 2019 | $4.13M | $-45.36M | 4.74% | -968.07% | -1,098.09% |
| 2020 | $15.14M | $-48.29M | 37.20% | -348.60% | -318.92% |
| 2021 | $30.17M | $-36.65M | 58.38% | -137.62% | -121.50% |
| 2022 | $43.11M | $-41.01M | 63.28% | -61.45% | -95.14% |
| 2023 | $33.88M | $-26.94M | 59.19% | -74.03% | -79.51% |
| 2024 | $28.54M | $-39.26M | 39.06% | -138.84% | -137.57% |